Rigor.
Access.
Legacy.
We advance the mechanistic science of fluid-based neurodegenerative biomarkers and translate it into diagnostic tools that reach communities around the world.
We are building a future in which blood tests can reveal neurodegenerative diseases early — widely accessible to communities around the world. Every diagnosis is the first step towards a cure.
Three ways to work with the lab
From mechanistic discovery to assay services, our door is open to academic and clinical partners worldwide.
01Science & Innovation
See how we decode the biology of blood-based biomarkers for Alzheimer's disease and related dementias.
Explore our science→
02Partnering with Karikari Lab
Grants, cohorts, co-authored programs and philanthropic giving — how partners and donors help build our studies.
Partner or donate→
03Laboratory services
Validated fluid biomarker assays available to external investigators through the University of Pittsburgh.
Visit pitt.edu/karikari→What the lab is up to
New paper out in Nature Communications from the Karikari Lab at Pitt Psychiatry — led by our team with collaborators across the University of Pittsburgh.
Read on LinkedIn →The Karikari Lab is representing at ASMS 2026 in San Diego — proud of our presenters showcasing cutting-edge proteomics and biomarker research this week.
Read on LinkedIn →Dr. Karikari is featured in the Pitt ADRC Pathways Newsletter, highlighted for his Nature Rising Star in Aging Research recognition and his vision for next-gen Alzheimer’s blood biomarkers.
Read on LinkedIn →Feed module — these three cards are samples drawn from the lab's recent public activity. On the live site this block is wired to the Karikari Lab LinkedIn page and refreshes automatically with the three most recent posts.
Get in touch with the team
Prospective trainees, collaborators and sample-sharing enquiries — tell us what you are working on.